Clinical trial
Effect of Dulaglutide on Glycemic Variability in Patients With Type 2 Diabetes
NCT04374578
Study timeline
Study start (actual)2020-05-08Date precision: day
Registry last updated2022-03-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetesunresolved
Interventions
Dulaglutide 1.5 MG/MLDRUG · verified · RxNorm: dulaglutide 1.5 MG/ML
Sponsors & collaborators
Shanghai Zhongshan Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04374578 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.